Clinical Trials Browser

Phase 1/2 × Active not recruiting × cabiralizumab × Clear all

NCT04331067 2025-04-23

Neoadjuvant Nivolumab and Chemotherapy in Patients With Localized Triple-negative Breast Cancer

Phase 1/2 Active not recruiting

15 enrolled 12 charts

Triple Negative Breast Neoplasms